Articles from Opentrons Labworks, Inc.

Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale cell engineering, today announced the Opentrons Flex® neoSwitch™ Workstation powered by the Neochromosome® neoSwitch platform for in-house antibody discovery. The Workstation enables labs to automate critical steps of the neoSwitch antibody discovery workflow, including high throughput purification of binders for rapid characterization. By combining the ease-of-use of the Flex workstation with the turnkey neoSwitch platform, it is now straightforward to onboard yeast-based antibody discovery and unlock cost and time savings up to ten-fold relative to conventional outsourcing.

Opentrons Labworks, Inc. today introduced its Opentrons Flex® Proteomics Workstation, an automated system for common proteomics workflows, including preparing mass spectrometry (MS) samples at a cost significantly below the six-figure range common in proteomics automation. It automates steps such as protein digestion (SP3), quantification, labeling, and purification, streamlining processes that typically require significant hands-on time for bench scientists.

Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, today announced it has surpassed 100 protocols for its flagship Opentrons Flex robot, providing labs with a more seamless way to automate time-consuming labor-intensive tasks and move more quickly towards scientific discoveries. The Flex now offers an industry-leading number of ready-to-run protocols in its open Protocol Library among benchtop automation platforms, achieving this milestone in just 18 months.

Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, today announced the launch of its Opentrons Flex High-Throughput NGS Workstation. The only high-throughput benchtop instrument of its kind available at less than $100K, it allows the most in-demand NGS library prep workflows run completely hands-free for up to 96 samples or more, depending on the technology. Popular sample prep technologies that can be run on the Flex High-Throughput NGS Workstation include whole genome, long read and single cell sequencing.

Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, today announced the launch of the Opentrons Flex™ Prep robot, paired with new no-code software that allows users to quickly set up a pipetting task and to execute that workflow all through the Flex Prep touchscreen. This innovative system integrates seamlessly into laboratory workflows, allowing users to set up pipetting tasks via an intuitive touchscreen interface. Flex Prep combines the simplicity of a pipette with the power and versatility of a liquid handler, providing scientists with both ease of use and enhanced capability. With the touchscreen software, users can develop, visualize, and run pipetting tasks in as little as a minute. This system offers a user-friendly experience that surpasses semi-automated solutions, while also being more affordable and versatile.

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the launch of Opentrons® for Education, an exclusive offering for educators to bring lab automation to the classroom. Opentrons is building a first-of-its-kind ecosystem for teaching with automation, which includes education pricing and support, along with access to a community of educators already teaching with Opentrons. Our goal is to make lab automation a universal skill.

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer. With over a decade of medical robotics, IP strategy, and product commercialization expertise, Dr. Cole will be responsible for establishing commercial and academic partnerships with leading research institutions and biopharma companies and creating novel product solutions for the company’s Opentrons Flex, the first liquid-handling robot designed to be compatible with “design-of-experiment” programs, including AI-driven agents utilizing large language models (LLMs).

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the launch of its new protocol library, offering plug-and-play protocols for all Opentrons robots, including the Opentrons Flex™. Opentrons is building a first-of-its-kind ecosystem for simplifying and scaling lab automation, which comprises the protocol library along with generative AI tools for protocol development, coupled with stringent wet- and dry-lab verification processes. The aim is to create the largest open-access set of robust liquid-handling automation protocols to streamline research across genomics, proteomics, cell biology, and synthetic biology.

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the launch of its automation marketplace, with tools and software from Opentrons’ partners that can be easily integrated into Opentrons robotics systems, catering to rapidly expanding sectors like drug discovery and microbiome research. Designed to streamline the research process and enable scientists to concentrate on making impactful discoveries, the marketplace functions as a comprehensive eCommerce hub, enabling customers to effortlessly access essential products, services, and support from Opentrons' commercial partners.

Pandemic Response Lab (PRL), a wholly owned subsidiary of Opentrons Labworks, Inc., today announced two new three-target monkeypox tests, each developed and performed by its New York and Maryland laboratories, respectively. These skin lesion tests qualitatively detect three different viral genome targets of increasing specificity: non-variola orthopoxvirus, monkeypox virus species and monkeypox virus clade II. Use of these three viral targets identified by the Centers for Disease Control and Prevention (CDC) enhances the ability to detect mutant monkeypox virus strains.

Opentrons Labworks, Inc., today announced the appointments of Eva Boratto as chief financial officer and member of the board of directors, and Veleka Peeples-Dyer as chief legal and compliance officer. The breadth of Boratto’s and Peeples-Dyer’s expertise and influence position the company to accelerate its strategic plans for growth and expansion in biotech automation, clinical diagnostics and synthetic biology.